Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2013

Open Access 01-12-2013 | Research article

Cost of illness of the stomach cancer in Japan - a time trend and future projections

Authors: Kayoko Haga, Kunichika Matsumoto, Takefumi Kitazawa, Kanako Seto, Shigeru Fujita, Tomonori Hasegawa

Published in: BMC Health Services Research | Issue 1/2013

Login to get access

Abstract

Background

Stomach cancer is one of the leading causes of cancer deaths in Japan. The objectives of this study were to estimate and project the economic burden associated with stomach cancer in Japan, and to identify the key factors that drive the economic burden of stomach cancer.

Methods

We calculated Cost of illness (COI) of 1996, 2002, 2008, 2014 and 2020 by using government office statistics and the COI method. We calculated direct cost and indirect cost (morbidity cost and mortality cost), and estimated the COI by summing them up.

Results

The number of deaths remained at approximately 50,000 in 1996–2008. COI was in downward trend from 1,293.5 billion yen in 1996 to 1,114.2 billion yen in 2008. Morbidity cost was 85.6 billion yen and 54.0 billion yen, mortality cost was 972.3 billion yen and 806.4 billion yen, and mortality cost per person was 19.4 million yen and 16.1 million yen in 1996 and 2008, respectively. Decrease of mortality cost that accounted for a large part of the COI (72.4% in 2008) was the major contributing factor. COI is predicted to decrease if the trend of health related indicators continues (442.8-1,056.1 billion yen depending on the model in 2020). Mortality cost per person is also predicted to decrease (9.5-12.5 million yen depending on the model in 2020).

Conclusions

If the trend of health related indicators continues, it is estimated that COI of stomach cancer would decrease. “Aging”, “change of the healthcare providing system” and “new medical technology” are considered as contributing factors of COI.
Appendix
Available only for authorised users
Literature
1.
2.
Nishimura Y, Mitsutake N, Nakanishi S, Konishi T: Cost analysis on stomach cancer treatment in Japanese hospitals. Gan To Kagaku Ryoho Japanese J Cancer Chemother. 2000, 27 (9): 1360-1368. (in Japanese)
3.
Koinuma N: Cancer economics in gastric cancer treatment. Nihon Rinsyo [Japanese J Clin Med]. 2008, 66 (Suppl 5): 639-652. (in Japanese)
4.
Asaka M: Strategies for extermination of gastric cancer from Japan. Nihon Rinsyo [Japanese J Clin Med]. 2011, 69 (1): 173-182. (in Japanese)
5.
6.
7.
Hodgson TA, Meiners MR: Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc. 1982, 60: 429-462. 10.2307/3349801.CrossRefPubMed
8.
Rice DP, Hodgson TA, Kopstein AN: The economic costs of illness: a replication and update. Health Care Financ Rev. 1985, 7: 61-80.PubMedPubMedCentral
9.
Rice DP: Cost-of-illness studies: fact or fiction?. Lancet. 1994, 344 (8936): 1519-1520. 10.1016/S0140-6736(94)90342-5.CrossRefPubMed
10.
11.
12.
13.
Hashimoto H, Ikegami N, Shibuya K, Izumida N, Noguchi H, Yasunaga H, Miyata H, Acuin JM, Reich MR: Cost containment and of care in Japan: is there a trade-off?. Lancet. 2011, 378: 1174-1182. 10.1016/S0140-6736(11)60987-2.CrossRefPubMed
14.
Wang K, Li P, Chen L, Kato K, Kobayashi M, Yamauchi K: Impact of the Japanese Diagnosis Procedure Combination-based Payment System in Japan. J Med Syst. 2010, 34 (1): 95-100. 10.1007/s10916-008-9220-2.CrossRefPubMed
15.
Miller LS, Zhang X, Novotny T, Rice DP, Max W: State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993. Public Health Rep. 1998, 113 (2): 140-151.PubMedPubMedCentral
16.
Warner KE, Hodgson TA, Carroll CE: Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control. 1999, 8 (3): 290-300. 10.1136/tc.8.3.290.CrossRefPubMedPubMedCentral
17.
Kirschstein R: Disease-Specific Estimates of Direct and Indirect Costs of Illness and NIH Support. 2000, Washington, DC: National Institutes of Health
18.
19.
20.
Tarricone R: Cost-of-illness analysis: What room in health economics?. Health Policy. 2006, 77: 51-63. 10.1016/j.healthpol.2005.07.016.CrossRefPubMed
21.
Byford S, Torgerson DJ, Raftery J: Cost of illness studies. BMJ. 2000, 13; 320 (7245): 1335.CrossRef
22.
Shiell A, Gerard K, Donaldson C: Cost of illness studies: an aid to decision-making?. Health Policy. 1987, 8: 317-323. 10.1016/0168-8510(87)90007-8.CrossRef
23.
Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M, for the Japan Gast Study Group: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008, 372: 392-397. 10.1016/S0140-6736(08)61159-9.CrossRefPubMed
24.
Miki K: Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006, 9: 245-253. 10.1007/s10120-006-0397-0.CrossRefPubMed
25.
Shin DW, Yun YH, Choi IJ, Koh E, Park SM: Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer. Helicobacter. 2009, 14 (6): 536-544. 10.1111/j.1523-5378.2009.00721.x.CrossRefPubMed
Metadata
Title
Cost of illness of the stomach cancer in Japan - a time trend and future projections
Authors
Kayoko Haga
Kunichika Matsumoto
Takefumi Kitazawa
Kanako Seto
Shigeru Fujita
Tomonori Hasegawa
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2013
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-13-283

Other articles of this Issue 1/2013

BMC Health Services Research 1/2013 Go to the issue

Research article

Effects of immigrant status on Emergency Room (ER) utilisation by children under age one: a population-based study in the province of Reggio Emilia (Italy)

Research article

Delivery of primary health care to persons who are socio-economically disadvantaged: does the organizational delivery model matter?

Study protocol

Rationale and design of the Multicenter Medication Reconciliation Quality Improvement Study (MARQUIS)

Research article

Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland

Research article

A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis

Research article

Consumer knowledge and availability of maternal and child health services: a challenge for achieving MDG 4 and 5 in Southeast Nigeria